about
Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian PerspectiveSelective Phosphodiesterase Inhibitors for Psoriasis: Focus on ApremilastCorrelations between psoriasis and inflammatory bowel diseasesAnalysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared lociCombined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility lociPsoriasis and comorbid diseases: Epidemiology.Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.Coherent somatic mutation in autoimmune disease.Repeated Paradoxical Aggravation of Preexisting Psoriasis during Infliximab Treatment for Crohn's Disease.Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort studyPolymorphisms of the IL12B and IL23R genes are associated with psoriasis.Update of the management of chronic psoriasis: new approaches and emerging treatment options.Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.Biological therapy for dermatological manifestations of inflammatory bowel diseasePsoriasis: emerging therapeutic strategies.What is a role of haeme oxygenase-1 in psoriasis? Current concepts of pathogenesis.Folic acid in general medicine and dermatology.National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.Psoriasis bench to bedside: genetics meets immunology.Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis.Making sense of the cause of Crohn's - a new look at an old disease.The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.Ustekinumab for the treatment of psoriasis.Strategies for improving the quality of care in psoriasis with the use of treatment goals--a report on an implementation meeting.Application of the dermatology life quality index in clinical trials of biologics for psoriasis.Adherence to medication in patients with psoriasis: a systematic literature review.Tumor necrosis factor-alpha and the cytokine network in psoriasis.Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy.Adalimumab in the treatment of immune-mediated diseases.Innate lymphoid cells are pivotal actors in allergic, inflammatory and autoimmune diseases.Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature.Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.Clinical diagnostic clues in Crohn's disease: a 41-year experience.Fulminant ulcerative colitis associated with steroid-resistant minimal change disease and psoriasis: a case report.Differential gene expression in disease: a comparison between high-throughput studies and the literature.Management of cutaneous disorders related to inflammatory bowel disease.Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course.Psoriasiform eruption induced by infliximab.Neonatal neutrophils with prolonged survival exhibit enhanced inflammatory and cytotoxic responsiveness.
P2860
Q26747639-07577DEA-F96F-4919-9A59-6A11B39F3217Q26781755-ECB1E91C-0412-4168-96B0-500035596EB4Q27024863-8846DFA7-A33B-4D80-9CF2-8E1A5904E21EQ28393236-7243F648-5F90-4E23-B9E8-F1BD81AAD9BFQ28924378-D31889C2-7033-4E58-87A0-D7D6CCB03160Q30235889-F52B40B4-368C-4E81-83ED-F3D124721D6FQ30419116-A35251A3-1161-4C79-B2D3-201C9DEDE974Q33837769-FB7E3B1A-2F69-43CB-9792-55DDA1F39109Q33904578-DD1B329F-FE01-4A12-AC95-D56B93F33C33Q34283073-81A9E3C8-7C81-4870-8606-E7A5E6F1E603Q34587531-A2688DD9-A7A0-4770-B10F-3B1A993A6269Q34620375-656DB7E4-CAAE-4DB3-BA83-6F1399AE5699Q34696734-DB3C64E5-C117-4EA5-B7B5-5AE373C11AC5Q35058744-E741C814-5223-4106-A8CE-F51D8095666DQ36028220-312100B1-8C02-44B2-87ED-CCE29D5FF109Q36780173-B99AE98B-F033-4195-BCD0-B25519C7C817Q36835583-28CC5111-A8E6-48A7-A7CB-57E3A60BACB0Q37027264-4E64F87C-2B01-4561-9F67-3D713BD3259DQ37336263-96F342EF-ACBC-4FE4-AE77-5BC15A4C6F1EQ37362082-4BC08E44-C61D-47D6-B248-6F0DBB4A7B7CQ37406946-8589DC8A-174C-4018-88CB-865BDEC49AC2Q37577712-3DCA9A64-3708-42AA-8344-CA50A2DEA456Q37766229-94B9CC82-5DDD-44B0-B21E-2D3B7621EDADQ37855945-2CB50050-11B1-44FA-8BCA-A9B0A6CEA2B7Q37862369-2BD94AEC-C4FC-47D4-80C0-C3B67BA02C6BQ37998917-4A309A5D-0A12-4198-BD14-DC521C25715EQ38042075-F85EF6FD-2821-4DAA-A3FA-43FB70DCBF0FQ38050307-8960A7E4-4E43-4CBE-AEAA-DE683A088242Q38150741-C9054CD9-38D2-4A48-A499-28DCFED55F9FQ38207760-1EBF5305-E3E9-441D-BE8C-53D4BBF0ACD3Q38500621-E20AF1F6-02FF-4282-8C3B-F42584631475Q38704121-BABD56F2-74F8-4294-A250-DE8A01255E26Q40893795-5BFC2C4E-CF0E-4752-8167-8D2C80B9EBB7Q41810072-4FEE3783-9127-4579-9712-A2820441374CQ42034577-23A7DBEA-37EC-4B35-B19B-9970E28A402DQ42375274-262E892F-39E8-4D5E-BEA8-7D7F0F481ACBQ42406766-EAE3AAE9-8610-4317-B15B-4EE2AF85695AQ44577959-BD420C11-B193-4E1A-BFEC-CB4D849B437FQ44741635-0E5680B5-31D9-432D-A957-0C4D4DAB52F3Q45213492-97AB2834-6EE6-4408-90A0-3C4726545846
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Connections between psoriasis and Crohn's disease.
@ast
Connections between psoriasis and Crohn's disease.
@en
type
label
Connections between psoriasis and Crohn's disease.
@ast
Connections between psoriasis and Crohn's disease.
@en
prefLabel
Connections between psoriasis and Crohn's disease.
@ast
Connections between psoriasis and Crohn's disease.
@en
P356
P1476
Connections between psoriasis and Crohn's disease.
@en
P2093
Alice B Gottlieb
David James Najarian
P304
805-21; quiz 822-4
P356
10.1067/MJD.2003.540
P407
P577
2003-06-01T00:00:00Z